Company: PACB
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001299130-25-000090
Chunk: 55

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 55
---
 pursuant to the terms of the Clawback Policy or as necessary or appropriate to comply with applicable laws.

New Plan Benefits . Our executive officers and non-employee directors have an interest in this proposal because they are eligible to receive Awards under the 2020 Plan, including that non-employee directors are eligible to receive certain automatic awards as specified in the Director Compensation Policy, as discussed above in the section titled “Director Compensation.” As of the date of the Annual Meeting and pursuant to our Director Compensation Policy, each individual who is a non-employee director as of the date of the Annual Meeting automatically will be granted an Award of stock options under the 2020 Plan with an aggregate value of $200,000 (generally determined based on its grant date fair value in accordance with U.S. generally accepted accounting principles, with any resulting fractional share rounded down) (the “Annual Award”), subject to being prorated based on the number of months of continuous service such director provided during the twelve (12) month period immediately preceding such Annual Meeting Date (with any partial month of service provided rounded up to a whole month) to the extent such individual’s service as a member of the Board of Directors commenced after the date of the Company’s immediately preceding annual meeting of stockholders. The following table sets forth the grant date fair value of the Annual Award to be granted to each of our non-employee directors on the date of the Annual Meeting, subject to the non-employee director’s continued service on our Board of Directors through such date, and without taking into account the current 65,000 total share limit with respect to such Annual Award for each non-employee director as described in footnote 1 in the table below. The number of Shares of our common stock that will be subject to this Annual Award will not be known until its date of grant. If our stockholders do not approve at the Annual Meeting the amendment to the 2020 Plan to increase the Shares issuable under the 2020 Plan, then the 2020 Plan will continue under its current terms, without such amendment, until its automatic termination in August 2030.

| 2025 Proxy Statement |     | 40 |

TABLE OF CONTENTS

| Name of Director                                             |     | Grant Date Fair Value of Stock 
                 Options ($)(1) |     | Number of Shares Subject to Stock 
 Options (#)(1)                    |
| William Ericson                                              |     |                        200,000 |     | ND                                |
| Randy Livingston                                             |     |